Literature DB >> 8152775

Nonarteritic ischemic optic neuropathy. The impact of tobacco use.

S M Chung1, C A Gay, J A McCrary.   

Abstract

BACKGROUND: Numerous associations to anatomic variation and systemic vascular disease have been made to anterior ischemic optic neuropathy (AION) but exogenous agents have not been emphasized. The authors studied the effect that smoking had in the development of AION. The relevance of other intraocular and systemic vascular disease to AION also is discussed.
METHODS: Over a 10-year period (January 1980-May 1990), nonarteritic AION was diagnosed in 148 patients, 137 of whom were included in this analysis.
FINDINGS: Of the 137 patients identified with nonarteritic AION, 28 smokers were statistically younger, at 51 years of age, compared with 83 nonsmokers whose mean age was 64 years (P = 0.005).
CONCLUSIONS: Cigarette smoking is an important risk factor in the development of AION. Cessation of smoking appears to reduce the risk of AION to that of the nonsmoking population.

Entities:  

Mesh:

Year:  1994        PMID: 8152775     DOI: 10.1016/s0161-6420(94)31266-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  Knowledge about the relationship between smoking and blindness in Canada, the United States, the United Kingdom, and Australia: results from the International Tobacco Control Four-Country Project.

Authors:  Ryan David Kennedy; Marlee M Spafford; Carla M Parkinson; Geoffrey T Fong
Journal:  Optometry       Date:  2011-05

2.  Risk Factors for Non-arteritic Anterior Ischaemic Optic Neuropathy in a Korean Population.

Authors:  Dae Hyun Kim; Gwang Rae Shin; Young Je Choi
Journal:  Neuroophthalmology       Date:  2017-01-11

3.  [Quantification of fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy].

Authors:  T Hirsch; A Remky; N Plange; M Kaup
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

4.  Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients.

Authors:  Michael S Lee; Daniel Grossman; Anthony C Arnold; Frank A Sloan
Journal:  Ophthalmology       Date:  2011-03-24       Impact factor: 12.079

Review 5.  [Anterior ischemic optic neuropathy: Etiology, pathogenetic mechanisms and therapy].

Authors:  R Unsöld
Journal:  Ophthalmologe       Date:  2008-09       Impact factor: 1.059

6.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

Review 7.  Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation.

Authors:  Rita C Tostes; Fernando S Carneiro; Anthony J Lee; Fernanda R C Giachini; Romulo Leite; Yoichi Osawa; R Clinton Webb
Journal:  J Sex Med       Date:  2008-03-04       Impact factor: 3.802

8.  Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or alpha-blockers.

Authors:  Dustin D French; Curtis E Margo
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis).

Authors:  Anthony C Arnold; Roberta M S Costa; Oana M Dumitrascu
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

10.  Anterior ischemic optic neuropathy associated with udenafil.

Authors:  In-Gun Kim; Dae Yune Kim
Journal:  Korean J Ophthalmol       Date:  2012-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.